HONG KONG – Looking to further its innovative efforts in drug development, pharma major Johnson & Johnson has partnered with Chinese liver disease expert Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ), as well as a score of other external companies.